graft-versus-host disease
SyndromeWikipedia
22
MENTIONS
7
EPISODES
5
PODCASTS
Search complete. 22 mentions across 7 episodes found for "graft-versus-host disease".
Sep 11, 2026
Tregs, Tape, and Tresses
T
11:00Tim PattonHOST
Yeah, actually, look, there's only one Treg therapy, I think, that's FDA approved.
T
11:06Tim PattonHOST
It's some sort of infusion of Treg cells that you do for like GVHD, right? I mean, that makes sense.
T
11:12Tim PattonHOST
Like bad GVHD is horrific.
T
11:15Tim PattonHOST
yeah ad and pemphigus and i mean pemphigus is bad but even there was like a t-reg study that that didn't that just closed down i don't know i this this therapy especially when we have all the other things we're going to get we're going to get more jack inhibitors we're going to get long acting like stepica barton we're just going to have so many other therapies i i
L
11:41Laura FerrisHOST
It is interesting that this is the disease that they chose to pursue.
Bone Marrow Transplant Basics For The PICU
J
28:21Jordan MilnerGUEST
And we select out the alpha beta T cells, which are 95% of your T cell population.
J
28:28Jordan MilnerGUEST
And they're also notorious for causing graft-versus-host disease.
A
28:32Amanda BradshawHOST
So we take those puppies out.
A
28:33Amanda BradshawHOST
Okay.
J
30:07Jordan MilnerGUEST
Uh-huh.
J
30:08Jordan MilnerGUEST
And so we're just waiting to see.
J
30:10Jordan MilnerGUEST
What I can say is a matched sibling donor transplant comes with a risk of 40% to 60% graft-versus-host disease.
J
30:17Jordan MilnerGUEST
Okay.
Dental Panning & Care Through the BMT Journey with Dr. Ryan Lee
R
5:37Ryan LeeGUEST
There's also a need to really distinguish the different types of transplants, right? An autologous transplant versus an allo.
R
5:45Ryan LeeGUEST
And again, we're not going to talk in depth about the CAR T cell therapy, but your risk of developing graft versus host disease is really case by case.
R
5:55Ryan LeeGUEST
Patient by patient can be very different.
R
5:57Ryan LeeGUEST
But I'm sad to say this.
20 MINS LATER
R
25:33Ryan LeeGUEST
So long-term survivorship and oral health for transplant recipients, bone marrow transplant survivors is minimize the invasive stuff and try to hold on to your teeth and gums for as long as possible.
R
25:45Ryan LeeGUEST
And while that might sound like cliche and just common sense, please know that your ability to just brush and floss is going to be different.
R
25:54Ryan LeeGUEST
In the setting of graft versus host disease, which almost everyone has some degree of, and it's not always a bad thing, that's also an indication that the transplant is working, right?
P
26:02Peggy BurkhardtHOST
A
The Person Beside the Patient: Joanne Claxton’s Caregiving Story
J
8:10Joanne ClaxtonGUEST
Yes, yes.
P
8:13Peggy BurkhardtHOST
Can you explain what graft-versus-host disease has meant for Adam in everyday life and what people really don't realize regarding living with it?
J
8:22Joanne ClaxtonGUEST
Yeah, so graft-versus-host disease is a strange one.
J
8:26Joanne ClaxtonGUEST
I mean, it's something I'd never heard of.
J
8:28Joanne ClaxtonGUEST
And I mean, I don't think you will have heard of it unless you're sort of on that cancer journey.
The Emotional Reality of Chronic GVHD with LCSW Lori Eberly
S
0:01speaker_0NARRATOR
Welcome to Marrowmasters Season 21, sponsored by Insight and Sanofi.
S
0:06speaker_0NARRATOR
This season, we'll focus on chronic graft-versus-host disease.
S
0:10speaker_0NARRATOR
You'll hear from survivors, clinicians, and more.
S
0:12speaker_0NARRATOR
We'll share their experiences, advice, coping mechanisms, updates, and tips so you can enjoy life to the fullest.
P
2:50Peggy BurkhardtHOST
Lori, let's talk more about the psychological distress.
P
2:53Peggy BurkhardtHOST
What is it and what can survivors do about it?
L
2:56Lori EberlyGUEST
I think it's really important that we name that upwards of 30% of people living with chronic graft-versus-host disease report depression or anxiety.
L
3:06Lori EberlyGUEST
And I don't say this to be a Debbie Downer.
Jennifer and Sean White will talk about their daughter Olivia who was diagnosed with Megakaryoblastic Leukemia which is a more aggressive form of Acute Myeloid Leukemia in February of 2024 and has been making dramatic progress recently with her health.
M
13:30Mark LevineHOST
At that time, how successful was the bone marrow transplant? And can you also talk, if you have any information on the alpha beta T cell depletion trial that was part of the transplant?
J
13:45Jennifer WhiteGUEST
So the alpha beta T cell depletion is so there's a machine and they use magnetics and it takes the T cells out, which helps prevent like GVHD.
J
13:59Jennifer WhiteGUEST
And I think Olivia was the 50th.
J
14:02Jennifer WhiteGUEST
child at Children's to do this trial.
5 MINS LATER
J
19:31Jennifer WhiteGUEST
So yeah, it can be life-threatening.
J
19:33Jennifer WhiteGUEST
But once they understood what it was and started treating it, it was no longer life-threatening as long as she was getting that infusion, weekly infusion.
M
19:44Mark LevineHOST
Yeah, I was reading about this alpha-beta T cell depletion I think one of the objectives of it and perhaps hopefully one of the reasons at the time that sounded good that they gave it to you was that the threat of graft versus host disease, GVHD, which is a very difficult disease to get, was the chances of this depletion trial would lessen
J
20:13Jennifer WhiteGUEST
the possibility
Colin Grant & Michael Rosen: What We Leave We Carry
C
20:56Colin GrantGUEST
Yeah, yeah.
M
20:56Michael RosenHOST
Graft Versus Host.
C
20:58Colin GrantGUEST
Yeah.
M
20:58Michael RosenHOST
Which was really interesting, 'cause that, you were going medical on us.